Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | MALT1 | Q9UDY8 | 8/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | TDP2 | O95551 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | NQO1 | P15559 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4251170 | 0.82 | AURKA (0.38) | IDO1MALT1LMNAKDM4EMEN1 | |
| SCHEMBL4251719 | 0.79 | MALT1 (0.39) | IDO1MALT1LMNAKDM4EMEN1 | |
| SCHEMBL4251143 | 0.77 | MALT1 (0.40) | IDO1MALT1LMNAKDM4EMEN1 | |
| SCHEMBL4253719 | 0.77 | MALT1 (0.40) | IDO1MALT1LMNAKDM4EMEN1 | |
| SCHEMBL4254312 | 0.69 | MALT1 (0.34) | IDO1MALT1LMNAKDM4EMEN1 | |
| SCHEMBL4258552 | 0.69 | DHODH (0.36) | IDO1MALT1LMNAKDM4EMEN1 | |
| SCHEMBL23423307 | 0.67 | KDM1A (0.39) | IDO1MALT1LMNAKDM4EMEN1 | |
| SCHEMBL9626749 | 0.65 | PDE4D (0.38) | IDO1MALT1LMNAKDM4EMEN1 | |
| SCHEMBL29590196 | 0.65 | KDM4E (0.62) | LMNAKDM4EMEN1ALDH1A1GLA | |
| SCHEMBL9626684 | 0.63 | PDE4D (0.41) | IDO1LMNAMAPTRAB9APDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090170926-A1 | Antiviral agents | MONASH UNIVERISTY (AU) | 2009-07-02 | — | — | US | claimed |
| US-20090170926-A1 | Antiviral agents | MONASH UNIVERISTY (AU) | 2009-07-02 | — | — | US | disclosed |
| US-20090170926-A1 | Antiviral agents | MONASH UNIVERISTY (AU) | 2009-07-02 | — | — | US | disclosed |
| US-20090170926-A1 | Antiviral agents | MONASH UNIVERISTY (AU) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170926-A1 | Antiviral agents | SLC10A1, HAVCR2, ZC3HAV1 | IDO1 321/4885MALT1 1025/4885LMNA 2853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.